<DOC>
	<DOC>NCT02068417</DOC>
	<brief_summary>The objective of the pilot study is to assess the feasibility of a full randomised, placebo-controlled clinical trial.The aim is to demonstrate that penile shockwave application in patients with erectile dysfunction of vascular origin leads to a greater increase in potency than in the control group.</brief_summary>
	<brief_title>Pilot Study of the Treatment of Erectile Dysfunction (ED) With Extracorporeal Shockwave Therapy (ESWT)</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>Erectile dysfunction for more than 6 months Informed consent Positive effect of phosphodiesterase type 5 inhibitor (PDE5i) IIEF15 score less than 20 No neurological disease Stable partnership for more than 3 months Age 1875 Total prostatectomy Another reason for ED except for vascular disorder Clinically significant hematological disease Heart stroke, Arrythmia during the last 6 months Cancer during the last 5 years Intake of antiandrogen ED treatment with the last 7 days IIEF score higher than, equal to 20 Previous shockwave treatment</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>IIEF score</keyword>
	<keyword>ED</keyword>
</DOC>